TWD 20.9
(-0.71%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1.19 Billion TWD | -19.65% |
2022 | 1.48 Billion TWD | 17.43% |
2021 | 1.26 Billion TWD | -14.89% |
2020 | 1.48 Billion TWD | 19.59% |
2019 | 1.24 Billion TWD | 10.79% |
2018 | 1.12 Billion TWD | -9.14% |
2017 | 1.23 Billion TWD | 18.51% |
2016 | 1.04 Billion TWD | 21.47% |
2015 | 856.55 Million TWD | 35.15% |
2014 | 633.76 Million TWD | -41.01% |
2013 | 1.07 Billion TWD | 63.59% |
2012 | 656.69 Million TWD | 30.68% |
2011 | 502.53 Million TWD | 23.78% |
2010 | 405.99 Million TWD | 44.59% |
2009 | 280.79 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 352.27 Million TWD | 28.65% |
2024 Q2 | 435.91 Million TWD | 23.74% |
2023 Q4 | 273.82 Million TWD | -0.68% |
2023 FY | 1.19 Billion TWD | -19.65% |
2023 Q1 | 321.03 Million TWD | -0.34% |
2023 Q3 | 275.7 Million TWD | -13.68% |
2023 Q2 | 319.38 Million TWD | -0.51% |
2022 Q3 | 308.37 Million TWD | -29.26% |
2022 Q1 | 417.12 Million TWD | 16.57% |
2022 FY | 1.48 Billion TWD | 17.43% |
2022 Q4 | 322.13 Million TWD | 4.46% |
2022 Q2 | 435.89 Million TWD | 4.5% |
2021 Q1 | 295.94 Million TWD | -34.58% |
2021 FY | 1.26 Billion TWD | -14.89% |
2021 Q4 | 357.83 Million TWD | 15.77% |
2021 Q3 | 309.09 Million TWD | 2.86% |
2021 Q2 | 300.51 Million TWD | 1.54% |
2020 Q4 | 452.39 Million TWD | 32.3% |
2020 Q2 | 319.29 Million TWD | -13.89% |
2020 FY | 1.48 Billion TWD | 19.59% |
2020 Q1 | 370.79 Million TWD | -1.15% |
2020 Q3 | 341.93 Million TWD | 7.09% |
2019 Q1 | 281.92 Million TWD | -6.82% |
2019 Q3 | 290.93 Million TWD | -0.8% |
2019 Q2 | 293.28 Million TWD | 4.03% |
2019 Q4 | 375.11 Million TWD | 28.93% |
2019 FY | 1.24 Billion TWD | 10.79% |
2018 Q2 | 256.23 Million TWD | -13.09% |
2018 Q3 | 266.75 Million TWD | 4.11% |
2018 Q4 | 302.54 Million TWD | 13.42% |
2018 FY | 1.12 Billion TWD | -9.14% |
2018 Q1 | 294.8 Million TWD | 14.55% |
2017 Q3 | 348.72 Million TWD | 3.26% |
2017 Q4 | 257.35 Million TWD | -26.2% |
2017 FY | 1.23 Billion TWD | 18.51% |
2017 Q1 | 289.27 Million TWD | -5.22% |
2017 Q2 | 337.71 Million TWD | 16.74% |
2016 FY | 1.04 Billion TWD | 21.47% |
2016 Q3 | 249.99 Million TWD | 1.05% |
2016 Q4 | 305.2 Million TWD | 22.08% |
2016 Q2 | 247.4 Million TWD | 4.01% |
2016 Q1 | 237.85 Million TWD | 4.17% |
2015 FY | 856.55 Million TWD | 35.15% |
2015 Q4 | 228.34 Million TWD | 0.0% |
2015 Q3 | 228.34 Million TWD | 14.21% |
2015 Q2 | 199.93 Million TWD | 0.0% |
2015 Q1 | 199.93 Million TWD | 53.8% |
2014 Q1 | 186.89 Million TWD | -33.3% |
2014 Q2 | 186.89 Million TWD | 0.0% |
2014 Q4 | 129.99 Million TWD | 0.0% |
2014 Q3 | 129.99 Million TWD | -30.45% |
2014 FY | 633.76 Million TWD | -41.01% |
2013 Q2 | 256.95 Million TWD | 0.0% |
2013 Q1 | 256.95 Million TWD | 46.96% |
2013 Q3 | 280.18 Million TWD | 9.04% |
2013 Q4 | 280.18 Million TWD | 0.0% |
2013 FY | 1.07 Billion TWD | 63.59% |
2012 FY | 656.69 Million TWD | 30.68% |
2012 Q3 | 174.84 Million TWD | 0.0% |
2012 Q4 | 174.84 Million TWD | 0.0% |
2012 Q2 | - TWD | 0.0% |
2011 FY | 502.53 Million TWD | 23.78% |
2011 Q2 | - TWD | 0.0% |
2011 Q4 | - TWD | 0.0% |
2010 FY | 405.99 Million TWD | 44.59% |
2010 Q4 | - TWD | 0.0% |
2009 FY | 280.79 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Excelsior Medical Co., Ltd. | 8.23 Billion TWD | 85.533% |
Apex Medical Corp. | 2.64 Billion TWD | 54.971% |
Applied BioCode Corporation | 395.16 Million TWD | -201.639% |